Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2022-06-22 2022-06-21
Drug Identification Number 02402165 02402165
Brand name MYLAN-ATOVAQUONE/PROGUANIL MYLAN-ATOVAQUONE/PROGUANIL
Common or Proper name ATOVAQUONE/PROGUANIL ATOVAQUONE/PROGUANIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients PROGUANIL HYDROCHLORIDE ATOVAQUONE PROGUANIL HYDROCHLORIDE ATOVAQUONE
Strength(s) 100MG 250MG 100MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT 100BT
ATC code P01BB P01BB
ATC description ANTIMALARIALS ANTIMALARIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-06-03 2022-06-03
Actual start date 2022-05-27 2022-05-27
Estimated end date 2022-06-28 2022-06-28
Actual end date 2022-06-21 2022-06-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments